Prolonged molecular remission in PML-RARalpha-positive acute promyelocytic leukemia treated with minimal chemotherapy followed by maintenance including the histone deacetylase inhibitor sodium valproate.

Mary McMullin; E. Nugent; Alexander Thompson; D. Hull; F.G. Jones; D. Grimwade

doi:10.1038/sj.leu.2403883

Prolonged molecular remission in PML-RARalpha-positive acute promyelocytic leukemia treated with minimal chemotherapy followed by maintenance including the histone deacetylase inhibitor sodium valproate.

Mary McMullin, E. Nugent, Alexander Thompson, D. Hull, F.G. Jones, D. Grimwade

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	1676-1677
Number of pages	2
Journal	Leukemia
Volume	19(9)
Issue number	9
DOIs	https://doi.org/10.1038/sj.leu.2403883
Publication status	Published - Sept 2005

ASJC Scopus subject areas

Hematology
Cancer Research

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1038/sj.leu.2403883

Cite this

@article{8a0e8505c0534627afd81b2fa7cfa83e,

title = "Prolonged molecular remission in PML-RARalpha-positive acute promyelocytic leukemia treated with minimal chemotherapy followed by maintenance including the histone deacetylase inhibitor sodium valproate.",

author = "Mary McMullin and E. Nugent and Alexander Thompson and D. Hull and F.G. Jones and D. Grimwade",

year = "2005",

month = sep,

doi = "10.1038/sj.leu.2403883",

language = "English",

volume = "19(9)",

pages = "1676--1677",

journal = "Leukemia",

issn = "1476-5551",

publisher = "NATURE PUBLISHING GROUP",

number = "9",

}

Prolonged molecular remission in PML-RARalpha-positive acute promyelocytic leukemia treated with minimal chemotherapy followed by maintenance including the histone deacetylase inhibitor sodium valproate. / McMullin, Mary; Nugent, E.; Thompson, Alexander et al.
In: Leukemia, Vol. 19(9), No. 9, 09.2005, p. 1676-1677.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - Prolonged molecular remission in PML-RARalpha-positive acute promyelocytic leukemia treated with minimal chemotherapy followed by maintenance including the histone deacetylase inhibitor sodium valproate.

AU - McMullin, Mary

AU - Nugent, E.

AU - Thompson, Alexander

AU - Hull, D.

AU - Jones, F.G.

AU - Grimwade, D.

PY - 2005/9

Y1 - 2005/9

UR - http://www.scopus.com/inward/record.url?scp=26944443973&partnerID=8YFLogxK

U2 - 10.1038/sj.leu.2403883

DO - 10.1038/sj.leu.2403883

M3 - Article

C2 - 16034463

SN - 1476-5551

VL - 19(9)

SP - 1676

EP - 1677

JO - Leukemia

JF - Leukemia

IS - 9

ER -

Prolonged molecular remission in PML-RARalpha-positive acute promyelocytic leukemia treated with minimal chemotherapy followed by maintenance including the histone deacetylase inhibitor sodium valproate.

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Cite this